116 related articles for article (PubMed ID: 35192416)
1. Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.
Hou J; Nguyen EV; Surudoi M; Roy MJ; Patel O; Lucet IS; Ma X; Daly RJ
Sci Signal; 2022 Feb; 15(722):eabj3554. PubMed ID: 35192416
[TBL] [Abstract][Full Text] [Related]
2. SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase.
Ounoughene Y; Fourgous E; Boublik Y; Saland E; Guiraud N; Recher C; Urbach S; Fort P; Sarry JE; Fesquet D; Roche S
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944965
[TBL] [Abstract][Full Text] [Related]
3. PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.
Lopez ML; Lo M; Kung JE; Dudkiewicz M; Jang GM; Von Dollen J; Johnson JR; Krogan NJ; Pawłowski K; Jura N
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15495-15504. PubMed ID: 31311869
[TBL] [Abstract][Full Text] [Related]
4. Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling.
Roy MJ; Surudoi MG; Kropp A; Hou J; Dai W; Hardy JM; Liang LY; Cotton TR; Lechtenberg BC; Dite TA; Ma X; Daly RJ; Patel O; Lucet IS
Nat Commun; 2023 Jun; 14(1):3542. PubMed ID: 37336884
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3.
Torosyan H; Paul MD; Forget A; Lo M; Diwanji D; Pawłowski K; Krogan NJ; Jura N; Verba KA
Nat Commun; 2023 Jun; 14(1):3543. PubMed ID: 37336883
[TBL] [Abstract][Full Text] [Related]
6. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases.
Liu L; Phua YW; Lee RS; Ma X; Jenkins Y; Novy K; Humphrey ES; Chan H; Shearer R; Ong PC; Dai W; Saunders DN; Lucet IS; Daly RJ
J Biol Chem; 2016 Oct; 291(41):21571-21583. PubMed ID: 27531744
[TBL] [Abstract][Full Text] [Related]
7. The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer.
Ding C; Tang W; Wu H; Fan X; Luo J; Feng J; Wen K; Wu G
Cancer Lett; 2019 Feb; 442():383-395. PubMed ID: 30472186
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway.
Croucher DR; Hochgräfe F; Zhang L; Liu L; Lyons RJ; Rickwood D; Tactacan CM; Browne BC; Ali N; Chan H; Shearer R; Gallego-Ortega D; Saunders DN; Swarbrick A; Daly RJ
Cancer Res; 2013 Mar; 73(6):1969-80. PubMed ID: 23378338
[TBL] [Abstract][Full Text] [Related]
9. PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer.
Agajanian M; Campeau A; Hoover M; Hou A; Brambilla D; Kim SL; Klemke RL; Kelber JA
PLoS One; 2015; 10(8):e0135748. PubMed ID: 26267863
[TBL] [Abstract][Full Text] [Related]
10. Dynamic phosphorylation of tyrosine 665 in pseudopodium-enriched atypical kinase 1 (PEAK1) is essential for the regulation of cell migration and focal adhesion turnover.
Bristow JM; Reno TA; Jo M; Gonias SL; Klemke RL
J Biol Chem; 2013 Jan; 288(1):123-31. PubMed ID: 23105102
[TBL] [Abstract][Full Text] [Related]
11. Production and purification of the PEAK pseudokinases for structural and functional studies.
Patel O; Surudoi M; Dai W; Hardy JM; Roy MJ; Lucet IS
Methods Enzymol; 2022; 667():1-35. PubMed ID: 35525538
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase Pyk2 regulates Arf1 activity by phosphorylation and inhibition of the Arf-GTPase-activating protein ASAP1.
Kruljac-Letunic A; Moelleken J; Kallin A; Wieland F; Blaukat A
J Biol Chem; 2003 Aug; 278(32):29560-70. PubMed ID: 12771146
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling.
Ding C; Tang W; Fan X; Wang X; Wu H; Xu H; Xu W; Gao W; Wu G
Cell Death Dis; 2018 Jul; 9(8):802. PubMed ID: 30038287
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization.
Ha BH; Boggon TJ
J Biol Chem; 2018 Feb; 293(5):1642-1650. PubMed ID: 29212708
[TBL] [Abstract][Full Text] [Related]
15. Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically 'actionable' signalling axis in triple negative breast cancer.
Yang X; Ma X; Croucher DR; Nguyen EV; Clark KC; Hu C; Latham SL; Zhao T; Bayly-Jones C; Nguyen VCB; Shin SY; Nguyen LK; Cotton TR; Chüeh AC; Kam Sian TCCL; Stratton MM; Ellisdon AM; Daly RJ
bioRxiv; 2024 Feb; ():. PubMed ID: 38405732
[TBL] [Abstract][Full Text] [Related]
16. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.
Sieg DJ; Ilić D; Jones KC; Damsky CH; Hunter T; Schlaepfer DD
EMBO J; 1998 Oct; 17(20):5933-47. PubMed ID: 9774338
[TBL] [Abstract][Full Text] [Related]
17. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
Agajanian M; Runa F; Kelber JA
Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
[TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
Thelemann A; Petti F; Griffin G; Iwata K; Hunt T; Settinari T; Fenyo D; Gibson N; Haley JD
Mol Cell Proteomics; 2005 Apr; 4(4):356-76. PubMed ID: 15657067
[TBL] [Abstract][Full Text] [Related]
19. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases.
Schlaepfer DD; Hunter T
Mol Cell Biol; 1996 Oct; 16(10):5623-33. PubMed ID: 8816475
[TBL] [Abstract][Full Text] [Related]
20. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies.
Nakamura K; Yano H; Schaefer E; Sabe H
Oncogene; 2001 May; 20(21):2626-35. PubMed ID: 11420674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
